Canada's ABK Biomedical secures $30 million in Series B funding

04/09/2019 1:37:00 PM (GMT)

Canadian medical device company ABK Biomedical, Inc. has landed $30 million in Series B funding round.

F-Prime Capital and Varian Medical Systems co-led the funding round.

ABK Biomedical is planning to use the funds to support the research and development, manufacturing, and the clinical development program designed for regulatory submission of both Eye90 and Easi-Vue.

The company has raised a total of $37.4 million in over three funding rounds.

ABK Biomedical

All success stories are prepared by Investsize editors which is selecting elite and remarkable information from press releases and anonymous news sources.There is no charge applied for any success stories which is published . Those published success stories are not investment advices and doesnt offer recommendations Alternate Text